Email: Haili.Cheng@UTSouthwestern.edu
Research Interests: His Research focuses on how dysregulation of lipid uptake and trafficking contributes to human diseases and Ubiquitin, protein degradation, proteasome, lipid metabolism, reverse cholesterol transport, Cardiovascular disease
Biography: Dr. Haili Cheng is a Researcher at Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, USA. He received his PhD, Molecular Medicine from The University of Texas Health Science Center at San Antonio in 2016, MS, Microbial and Biochemical Pharmacy from Peking Union Medical College & Tsinghua University, China in 2010 and BS, Biotechnology from Beijing Normal University, China in 2007. He worked as a Post-doctoral Researcher Fellow at The University of Texas Health Science Center at San Antonio, USA in 2016-2017. He work at The University of Texas Southwestern Medical Center from 2017 to present.
Poster Presentation
- Cheng H, Choe V, Rao H. XPC promotes MDM2-mediated degradation of the p53 tumor suppressor. Science Research Conferences: Ubiquitin and Cellular Regulation. June15-20, 2014, Saxtons River, VT, USA.
Oral Presentation
- How does Rad4 function in proteolysis? Molecular Medicine Department Retreat, Aug 2012, San Antonio, TX, USA.
- Mechanistic role and physiological function of Rad4 in proteolysis. Molecular Medicine Department Retreat, Aug 2013, San Antonio, TX, USA.
- Regulation of centromere histone H3 variant by ubiquitin-proteasome pathway. Molecular Medicine Department Retreat, Aug 2014, San Antonio, TX, USA.
- Regulation of Centromere Histone H3 Variant by Ubiquitin-Proteasome Pathway. Molecular Medicine Department Retreat, Aug 2015, San Antonio, TX, USA.
- Histone H3 variant Cse4 is regulated by multiple proteolytic pathways. Molecular Medicine Department Retreat, Aug 2016, San Antonio, TX, USA